Antiangiogenic potential of camptothecin and topotecan

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 5, 1999, Pages 411-416

  Clements, Mark K ^a,b   Jones, Carleton B ^a   Cumming, Melinda ^a   Daoud, Sayed S ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Camptothecin; Differentiation; Endothelial cells; TNP 470; Topotecan

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DNA; FUMAGILLOL CHLOROACETYLCARBAMATE; TOPOTECAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; CAMPTOTHECIN; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; LIPOSOMES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; TOPOTECAN; UMBILICAL VEINS;

EID: 0032885043     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050997     Document Type: Article

References (41)

1. 1. Aller P, Rius C, Mata F et al. (1992) Camptothecin induces differentiation and stimulates the expression of differentiation-related genes in U-937 promonocytic leukemia cells. Cancer Res 52: 1245
2. 2. Auerbach R, Kubai L, Knighton D, Folkman J (1974) A simple procedure for the long term cultivation of chicken embryos. Dev Biol 41: 391
3. 3. Bagavandoss P, Wilks JW (1990) Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun 170: 867
4. 3. Cancer Chemother Pharmacol 34: 175
5. 5. Clements MK, Wasi S, Daoud SS (1996) Camptothecin exhibits selective cytotoxicity towards human breast carcinoma as compared to normal bovine endothelial cells in vitro. Anticancer Drugs 7: 851
6. 6. Coll JM, Hickey RJ, Wei Y, Malkas LH (1996) The human cell multiprotein DNA replication complex (MRC): the effect of camptothecin on its ability to support in vitro DNA synthesis. Cancer Chemother Pharmacol 39: 97
7. 7. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082
8. 8. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582
9. 9. Daoud SS, Fetouh MI, Giovanella BC (1995) Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts. Anticancer Drugs 6: 83
10. 10. Del Bino GJ, Skierski J, Darzyniewicz Z (1991) The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60. Exp Cell Res 195: 485
11. 11. Denkamp J (1993) Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 66: 181
12. 12. Engineer M, Brown NS, Ho DHW, Newman RA, Bulger RE (1989) A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats. Toxicology 59: 151
13. 13. Fan TP, Jagger R, Bicknell R (1995) Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57
14. 14. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4
15. 15. Folkman J, Hausdenschild C, Zetter B (1979) Long term culture of capillary endothelial cells. Proc Natl Acad Sci USA 76: 5217
16. 16. Fotiss T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368: 237
17. 17. Fox BS, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL (1993) Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 53: 4161
18. 18. Gasparini G, Harris AL (1995) Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13: 765
19. 19. Gimbrone M, Cotran R, Folkman J (1974) Tumor growth neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst 52: 413
20. 20. Hoffman R, Paper DH, Donaldson J, Vogl H (1996) Inhibition of angiogenesis and murine growth by laminarin sulphate. Br J Cancer 73: 1183
21. 21. Hsiang YH, Lihou MG, Liu LF (1989) Arrest of DNA replication by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49: 5077
22. 22. Iruela-Arispe ML, Bornstein P, Sage EH (1991) Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88: 5026
23. 23. Jones CB, Clements MK, Wasi S, Daoud SS (1997) Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells. Cancer Chemother Pharmacol 40: 475
24. 24. Kim KJ, Li B, Winter J, Armanini M, Gillett N, Philips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis-suppressed tumor growth in vivo. Nature 362: 841
25. 25. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and Taxol. Cancer Res 57: 81
26. 26. Knighton D, Ausprunk K, Tapper D, Folkman J (1977) Avascular and vascular phases of tumor growth in the chick embryo. Br J Cancer 35: 347
27. 27. Kobayashi H, Hasuda K, Aoki K, Taniguchi S, Baba T (1990) Systemic chemotherapy in tumor-bearing rats using high-dosing cis-diamminedichloroplatinum(II) with low nephrotoxicity in combination with angiotensin II and sodium thiosulfate. Int J Cancer 45: 940
28. 28. Kowalski J, Kwan HH, Prionas SD, Allison AC, Fajardo LF (1992) Characterization and applications of the disc angiogenesis system. Exp Mol Pathol 56: 1
29. 29. Kudelka AP, Levy T, Verschraegen CF et al. (1997) A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res 3: 1501
30. 30. Kusada M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J (1991) Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174: 1070
31. 31. Nelson MJ, Conley FK, Fajardo LF (1993) Application of the disc angiogenesis system to tumor-induced neovascularization. Exp Mol Pathol 58: 105
32. 32. O'Reily MS, Boehm T, Shing Y et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 1-20
33. 33. Pommier Y (1996) Eukaryotic DNA topoisomerase I: genome gate keeper and its intruders, camptothecins. Semin Oncol 23: 1
34. 34. Rak JW, St Croix BD, Kerbel RS (1995) Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 6: 3
35. 35. Schirner M, Hoffmann J, Menrad A, Schneider MR (1998) Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res 4: 1331
36. 36. Tanaka T, Konno H, Matsuda I, Nakamura S, Baba S (1995) Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res 55: 836
37. 37. Volpert OV, Stellmach V, Bouck N (1995) The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res Treat 36: 119
38. 38. Vukanovic J, Passanti A, Hirata T, Traystman RJ, Hartley AB, Isaacs JT (1993) Antiangiogenic effects of the quinoline-3-carboxamide linoamide. Cancer Res 53: 1833
39. 39. Wellstein A, Zugmaier G, Califano JA, Kern F, Paik S, Lippman ME (1991) Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83: 716
40. 40. Yamamoto T, Sudo K, Fujita T (1994) Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res 14: 1
41. 41. Yanas T, Tamura M, Fujita K, Kodama S, Tanaka S (1993) Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cells lines in vitro and in vivo. Cancer Res 53: 2566